BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6227162)

  • 1. [Discontinuous plasma exchange with the conventional hemodialysis technic and blood cell centrifugation].
    Achenbach H; Haustein B; Baumann I; Raabe F; Meissner S; Kubel M
    Z Urol Nephrol; 1983 Jul; 76(7):465-72. PubMed ID: 6227162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent developments in high-dose immunoglobulin therapy: therapeutic plasma exchange, autoimmune diseases].
    Kalden JR; Schranz W; Lösch G; Krapf F; Bartels O
    Beitr Infusionther Klin Ernahr; 1982; 9():48-59. PubMed ID: 6216881
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic plasmapheresis and plasma exchange.
    Patten E
    Crit Rev Clin Lab Sci; 1986; 23(2):147-75. PubMed ID: 3081298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [10 years plasma exchange with the IBM (Cobe) 2997].
    Franz HR; Hohl-Taheri M; Kraatz B; Kühnl P; Neppert J
    Beitr Infusionsther; 1990; 26():147-9. PubMed ID: 1703815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of complement components and alpha 1-antitrypsin during plasma exchange.
    Csípö I; Bedö Z; Sipka S; Lebedin JS; Chuchalin AG; Szegedi G
    Acta Med Hung; 1991; 48(3-4):211-7. PubMed ID: 1822859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of emergency situations in autoimmune diseases with plasma exchange].
    Samtleben W; Blumenstein M; Habersetzer R; Gurland HJ; Link F; Meurer M; Besinger UA
    Acta Med Austriaca; 1982; 9(3):93-7. PubMed ID: 7148354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-exchange and in vivo immunoabsorption of isohemagglutinins in bone marrow transplantation across major ABO barrier.
    Iacone A; D'Arcangelo L; Di Bartolomeo P; Di Girolamo G; Dragani A; Torlontano G
    Haematologica; 1982; 67(6):874-84. PubMed ID: 6819193
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of plasmapheresis].
    Del Favero A; Morelli A; Narducci F
    Clin Ter; 1981 Jan; 96(1):93-9. PubMed ID: 6786819
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic plasma exchange: indications and results].
    Roujeau JC; Quaranta JF; Guillevin L; Cassuto JP; Chalopin JM; Gajdos P; Sobel A; Rifle G
    Ann Med Interne (Paris); 1984; 135(4):308-27. PubMed ID: 6236729
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extensive plasma exchange in ABO-incompatible bone marrow transplantation ].
    Osterwalder B; Gratwohl A; Bannert P; Müller M; Nissen C; Burri HP; Speck B
    Ther Umsch; 1982 Jul; 39(7):519-23. PubMed ID: 6750836
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma exchange (plasmapheresis).
    Hughes GR
    Agents Actions Suppl; 1980; 7():62-5. PubMed ID: 6941688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic plasma exchange.
    Shumak KH; Rock GA
    N Engl J Med; 1984 Mar; 310(12):762-71. PubMed ID: 6199669
    [No Abstract]   [Full Text] [Related]  

  • 13. What are the established clinical indications for therapeutic plasma exchange and how important is the choice of replacement fluid for efficacy of therapeutic plasma exchange in these situations?
    Vox Sang; 1982 Nov; 43(5):270-95. PubMed ID: 6216664
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-filtration plasmapheresis.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma exchange in clinical practice].
    van de Wiel A; Zwaveling JH; Rommes JH; Imhof JW
    Ned Tijdschr Geneeskd; 1982 Oct; 126(40):1822-6. PubMed ID: 7144947
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic plasma exchange reduces ABO titers to permit ABO-incompatible renal transplantation.
    Tobian AA; Shirey RS; Montgomery RA; Tisch DJ; Ness PM; King KE
    Transfusion; 2009 Jun; 49(6):1248-54. PubMed ID: 19210321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Favorable results of plasmapheresis in severe myasthenia gravis].
    Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma exchange in progressive lupus nephritis].
    Hörmann A; Keusch G; Burger R; Briner J; Binswanger U; Gmür J
    Schweiz Med Wochenschr; 1982 Jun; 112(24):853-8. PubMed ID: 7112055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience with intensive plasma exchange].
    Gratwohl A; Cornu P; Nissen C; Ruggero D; Osterwalder B; Speck B
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1449-51. PubMed ID: 7280593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.